To meet the vast needs for obesity care for older adults in the US, primary care clinicians and their teams must receive adequate education and resources to recommend non–incretin mimetic medications to appropriate patients with an FDA indication for treatment, such as obesity or overweight with comorbidities. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.